Saturday, December 14, 2019

Scientists discover new technique that shows how cancer cells grow

Researchers have observed how stem cell mutations quietly arise and spread throughout a widening field of the colon until they eventually predominate and become malignant. Using an innovative modelling system in mice, the researchers visually tagged  colon cancer mutations by causing stem cells to glow. Mutations found in colon cancer were then visualised in the animals, illuminating a sort of tournament-to-the-death underway in the intestine in which one or another mutation prevailed over the others to become the driving force of a malignancy.

Joshua Snyder, PhD, assistant professor in the Departments of Surgery and Cell Biology at Duke University, said: “This study provides new insight into the previously invisible process in which mutant precancerous stem cells spread throughout the colon and seed cancer.” The study was published in the journal of Nature Communications.

“Our technique sets a firm foundation for testing new therapies that interrupt this early, pre-malignant process. We hope to one day target and eliminate these stealth precancerous cells to prevent cancer,” Snyder said.

In this way, the researchers found key differences in how the intestinal habitats common to babies and adults grow pre-cancerous fields of mutant cells. At a critical period, new born babies are sensitive to the effects of mutations within intestinal stem cells.

This insidiously seeds large fields of premalignant mutated cells throughout the intestine — a process called field cancerization — that dramatically increases cancer risk. These fields of mutated cells can grow and spread for years without being detected by current screening technologies; often, they remain harmless, but under proper conditions, these can rapidly become cancerous later in adults.

The researchers also observed that some colon cancer mutations found in patients can lead to a striking increase in the fertility of the environment surrounding precancerous fields. Ultimately, this leads to the rapid spread of fields throughout the intestine, with lethal consequences. Certain common mutations that arise from external sources, such as an injury or an environmental exposure, could also disrupt the environment surrounding the stem cell and lead to the rapid growth and spread of precancerous fields.

These occurrences can be especially lethal in adults and occur much more rapidly than previously expected — as if dropping a match on a drought-stricken forest. “Field cancerisation has been suggested to be the defining event that initiates the process of cancer growth, including cancers of the breast, skin, and lung,” said Snyder.

“Our technique allows us to model how premalignant cells compete and expand within a field by simple fluorescent imaging, potentially leading to earlier diagnosis and treatment.”

this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     
https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
  
 
  


Labels: , , , , , , , , ,

Saturday, June 08, 2019

Non-surgical therapy to treat brain tumors

Brain tumour is one of the most aggressive forms of malignant tumors and the survival period for a patient is mostly 14 months. Every year about 8,50,000 new cancer cases are diagnosed in India, of which 5,80,000 cancers result in death. More than 60% of these affected patients are in the prime of their life between the ages of 35 and 65 years.

The standard treatment options of cancer include surgery, chemotherapy and radiotherapy which mostly result in partial cure with multiple side effects, deterioration of quality of life which further compounds the emotional and psychological distress associated with cancer patients.

Glioblastoma Multiforme (GBM) is one of the most common type of brain tumors that are known to occur majorly in adults and also in children to some extent. Despite the variety of treatment options available today, malignant gliomas consistently remain a high-mortality disease characterized by a swift and disastrous clinical progression.

Sequentially Programmed Magnetic Field (SPMF) Therapy pioneered and patented by Dr. V G Vasishta have successfully saved and revived lives of over 500 brain tumor cancer patients.With SPMF Therapy, such patients have been treated successfully who have survived for more than five years on average.

SPMF is a unique type of treatment that is non-invasive and safe, painless, affordable, scientifically proven and most effective treatment for brain tumor. A patient’s condition is evaluated using MRI and the Karnofsky Performance Score (KPS) which are the gold standards for evaluating the efficacy of a therapy. This treatment is administered through an advanced medical device called AKTIS SOMA. This therapy is conducted over a 28-day period (one hour a day).

SPMF is a non-surgical treatment that helps degenerate cells in cancer. It has proved to be effective in the treatment of different types of cancer. This technology produces highly complex sequentially programmed magnetic fields, which are computer-controlled and can be precisely focused on to the target tissues with the help of laser guides.

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                    PS- THOSE INTERESTED IN RECIPES ARE FREE TO  VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/                                                                                                                                                FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                  https:// kneereplacement-stickclub.blogspot.com/  

                            FOR CROCHET DESIGNS                                                                                                                                                                                                https://gscrochetdesigns.blogspot.com

Labels: , , , , , , , , , ,

Friday, May 10, 2019

Imaging technique could enable surgeons to see and remove malignant tumours with ease

Researchers have developed a new imagining technique that could enable surgeons to clearly see malignant growth that is often difficult to completely eliminate. The technique uses a synthetic version of a compound found in scorpion venom.

The new imagining technique uses a special high-sensitivity near-infrared camera, along with the imaging agent tozuleristide or BLZ-100. The agent contains a synthetic version of an amino acid compound found in scorpion venom.


Like the natural form of the compound, the synthetic version is not toxic and binds to tumour cells. It is attached to a fluorescent dye that glows when stimulated by a near-infrared laser.


Viewed through the cameras, the imaging agent might allow neurosurgeons to detect the boundaries between tumours and healthy brain tissue during surgery, improving the opportunity for surgeons to remove tumour cells while sparing normal brain tissue.


With this fluorescence, you see the tumour so much clearer because it lights up like a Christmas tree, said senior author of the study.


This is important because of the sprawling nature of gliomas, the type of brain tumours imaged during the trial. Gliomas are highly lethal and comprise about 33 % of all brain tumours.

They fan infiltrate brain tissue with tentacle-like structures, making them difficult to distinguish from normal brain tissue. They typically do not respond to traditional therapies such as chemotherapy and radiation. The key to extending patient survival depends on a surgeon's ability to detect and remove all parts of the tumour.


In the clinical trial, 17 adult patients with brain tumours were given varying doses of BLZ-100 before surgery. Despite the varying amounts of the drug given, the majority of tumours fluoresced, including both high-and-low-grade gliomas.


After surgery, patients were monitored for 30 days. Investigators found that none of the patients had any serious adverse responses to the drug and that the imaging system was safe and could be useful for imaging the brain tumours during surgery.


More clinical trials are needed to further evaluate the safety of the imaging system and demonstrate the system's effectiveness before BLZ-100 can gain approval from the givernment, and the camera used in the trial must be refined before it can be used seamlessly in an operating room. But the researcher said the clinical trial results were promising.


For a surgeon, this seamless integration of fluorescence imaging into the surgical microscope is very appealing, he said.


Unlike other experimental systems that are bulkier or rely on multiple cameras, the new imaging system uses a single camera that takes both near-infrared and while-light images by alternating between a laser and normal white lights at very high speeds. This technology enables surgeons to easily switch back and forth between normal vision using a surgical microscope and fluorescent super-vision on a nearby monitor, in real time.


The next phase of this research, already underway, is a clinical trial involving paediatric brain tumours. This trial will serve as a data set for potential government approval. A similar adult clinical trial is also being planned.


This technique in this study holds great promise not only for brain tumours but for many other cancer types in which we need to identify the margins of cancers. The ultimate goal is to bring greater precision to the surgical care we provide to our patients, said the doctor.


THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                    PS- THOSE INTERESTED IN RECIPES ARE FREE TO  VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/    
                                                                                                                                                     FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                  https:// kneereplacement-stickclub.blogspot.com/  
         
                   FOR CROCHET DESIGNS                                                                                                                                                                                                  https://gscrochetdesigns.blogspot.com

Labels: , , , , , , , , , , ,

Tuesday, February 23, 2016

Sugar may help detect cancer, suggests new study

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOUR PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.



FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/

FOR CROCHET DESIGNS- http://My Crochet Creations.blogspot.com/



A team working with Johns Hopkins University has developed a new imaging technique for magnetic resonance tomography. 
Ordinary sugar may be used in imaging techniques to detect cancer, suggests a new study that found malignant tumours show higher sugar consumption than surrounding tissue.

"If sugar replaces metal as a contrast agent in the body, it can also have a positive psychological effect and make patients calmer," said Linda Knutsson, senior lecturer at Lund University in Sweden. A tumour's properties can be examined by injecting a small amount of sugar into it, and then measuring how much sugar the tumour consumes. The more sugar the tumour consumes, the more malignant it is.

Knutsson is working with a team from Johns Hopkins University in the US, which has developed a new imaging technique for magnetic resonance tomography. The collaboration has resulted in the new imaging technique being combined with the testing of natural sugar as a replacement for metal in contrast agents.

It is the first time a non-synthetic contrast agent has been used in human magnetic resonance tomography examinations, and the results are promising, researchers said. The uptake of sugar is higher in the tumour than in healthy tissue according to the results of tests carried out by researchers.

The tests were carried out on three persons with a brain tumour and four healthy persons. "Metal-based contrast agents cost more than sugar-based agents. Accordingly, this could lead to a reduction in medical care costs," said Knutsson.

Labels: , , , ,

Tuesday, May 13, 2014

Trials for ‘safer’ cancer therapy a success in India

Phase II clinical trials of Dendritic Cell Therapy (DCT), often referred to as the fourth flank against cancer after chemotherapy, radiotherapy and surgery, have successfully been completed across six sites in India. The drug controller’s approval has now been sought to make the therapy available to patients with malignant solid tumours. It is likely to cost anywhere between Rs 5-7 lakh.

The trial results published in the journal Cytotherapy showed that DCT is safe. In 51 patients with refractory cancer (with a life expectancy of three months or less) a median overall survival of 397 days was recorded. But researchers said the trials were conducted on patients with an advanced stage of the disease, and that ideally therapy should be started earlier.

The US Food and Drug Administration has approved DCT for some forms of solid cancer. It is also being used in China, Korea, Singapore and some countries of the European Union.

DCT involves harvesting blood cells (monocytes) in the laboratory, into dendritic cells, making them more potent with the introduction of cytokines, interleukins and growth factors. These are then reintroduced into the body in the form of a vaccine-like injection. Dendritic cells function as antigen presenting cells. In a normal person the cell is not present in sufficient quantities to trigger a potent immune response. Unlike conventional anti-cancer therapy, DCT does not involve any side-effects.

Discoveries leading to this therapy had won the Nobel Prize for medicine in 2011. Ralph Steiman (who got half of the award) had identified dendritic cells in 1973 and pioneered the therapy later to treat his own pancreatic cancer.

Dr. Ashok Vaid, senior Consultant, Medanta Medicity (a trial site) said, “Immunotherapy offers new hope for patients suffering from late stages of cancer.The clinical trial proves it improves the patients life span and makes a qualitative difference to the kind of life a patient leads”.


PS- THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.
PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-
HTTP:GSEASYRECIPES.BLOGSPOT.COM/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/

FOR CROCHET DESIGNS


HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM

Labels: , , , , , , , , , , , , ,

Monday, October 14, 2013

Ways to identify and isolate pre-tumour liver cancer progenitor cells discovered

Researchers  have for the first time isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma (HCC) tumours, which is the most common form of liver cancer.
The researchers  found ways to identify and isolate the HCC progenitor cells (HcPC) long before actual tumours were apparent.
The study's lead author  reported that HcPC take form within dysplastic or abnormal lesions often found in damaged or cirrhotic livers.
Study co-author said that it was never established whether dysplastic lesions are just a regenerative (healing) response of the liver triggered by tissue damage or are actually pre-malignant lesions that harbour tumour progenitor cells.
He said that their study showed that HcPC are likely derived from dysplastic lesions, can progress to malignant tumours and further demonstrate that the malignant progression of HcPC to full-blown liver cancer depends upon the micro-environment that surrounds them.
The researchers were able to characterize HcPC based on several bio-markers that distinguish them from normal cells. They also identified cellular signalling pathways activated in HcPC that are critical "to their malignant potential."
The findings may have profound implications for treating HCC which is difficult to diagnose and treat, with poor prognoses for patients.
He said identifying pre-malignant lesions in high-risk patients based on HcPC markers would allow for earlier detection and therapeutic interventions.

ps- this is only for information, always consult you physician before having any particular food/ medication/exercise/other remedies.
ps- those interested in recipes are free to view my blog-

http://gseasyrecipes.blogspot.com/


for info about knee replacement, you can view my blog-


http://Knee replacement-stick club.blogspot.com/


for crochet designs


http://My Crochet Creations.blogspot.com

Labels: , , , , , , , , , , ,

Monday, September 23, 2013

Switch controlling growth of aggressive brain tumour cells identified

Researchers have identified a cellular switch that can be turned off and on, to slow down, and eventually restrict the growth of the most commonly diagnosed and aggressive malignant brain tumour.
The findings show that the protein RIP1 acts as a mediator of brain tumor cell survival, either protecting or destroying cells.
According to the researchers the protein, found in most glioblastomas, can be targeted to develop a drug treatment for these highly malignant brain tumors.
Senior author , said that their study identifies a new mechanism involving RIP1 that regulates cell division and death in glioblastomas.
She said that for individuals with glioblastomas, this finding identified a target for the development of a drug treatment option that currently does not exist.
In the study, researchers used animal models to examine the interactions of the cell receptor EGFRvIII and RIP1. Both are used to activate NFkB, a family of proteins that is important to the growth of cancerous tumour cells. When RIP1 is switched off in the experimental model, NFkB and the signalling that promotes tumour growth is also inhibited. Furthermore, the findings show that RIP1 can be activated to divert cancer cells into a death mode so that they self-destruct.


ps- this is only for information, always consult you physician before having any particular food/ medication/exercise/other remedies.

ps- those interested in recipes are free to view my blog-

http://gseasyrecipes.blogspot.com/


for info about knee replacement, you can view my blog-


http://Knee replacement-stick club.blogspot.com/


for crochet designs


http://My Crochet Creations.blogspot.com

Labels: , , , , , , , , , , , , , , ,